{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T15:26:51Z","timestamp":1794842811599,"version":"4.9.1"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Arag\u00f3n Government (Grupo de Investigaci\u00f3n A21_20R),"},{"name":"National Academy of Sciences of Costa Rica"},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2019-107601RA-C32 and PID2019-107601RB-C31 financed by MCIN\/AEI\/ 10.1303910.13039\/501100011033"],"award-info":[{"award-number":["PID2019-107601RA-C32 and PID2019-107601RB-C31 financed by MCIN\/AEI\/ 10.1303910.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2019-107601RA-C32 and PID2019-107601RB-C31 financed by MCIN\/AEI\/ 10.1303910.13039\/501100011033"],"award-info":[{"award-number":["PID2019-107601RA-C32 and PID2019-107601RB-C31 financed by MCIN\/AEI\/ 10.1303910.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["PID2019-107601RA-C32 and PID2019-107601RB-C31 financed by MCIN\/AEI\/ 10.1303910.13039\/501100011033"],"award-info":[{"award-number":["PID2019-107601RA-C32 and PID2019-107601RB-C31 financed by MCIN\/AEI\/ 10.1303910.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Cattle brucellosis is a severe zoonosis of worldwide distribution caused by\n                    <jats:italic>Brucella abortus<\/jats:italic>\n                    and\n                    <jats:italic>B. melitensis<\/jats:italic>\n                    . In some countries with appropriate infrastructure, animal tagging and movement control, eradication was possible through efficient diagnosis and vaccination with\n                    <jats:italic>B. abortus<\/jats:italic>\n                    S19, usually combined with test-and-slaughter (T\/S). Although S19 elicits anti-smooth lipopolysaccharide antibodies that may interfere in the differentiation of infected and vaccinated animals (DIVA), this issue is minimized using appropriate S19 vaccination protocols and irrelevant when high-prevalence makes mass vaccination necessary or when eradication requisites are not met. However, S19 has been broadly replaced by vaccine RB51 (a rifampin-resistant rough mutant) as it is widely accepted that is DIVA, safe and as protective as S19. These RB51 properties are critically reviewed here using the evidence accumulated in the last 35 years. Controlled experiments and field evidence shows that RB51 interferes in immunosorbent assays (iELISA, cELISA and others) and in complement fixation, issues accentuated by revaccinating animals previously immunized with RB51 or S19. Moreover, contacts with virulent brucellae elicit anti-smooth lipopolysaccharide antibodies in RB51 vaccinated animals. Thus, accepting that RB51 is truly DIVA results in extended diagnostic confusions and, when combined with T\/S, unnecessary over-culling. Studies supporting the safety of RB51 are flawed and, on the contrary, there is solid evidence that RB51 is excreted in milk and abortifacient in pregnant animals, thus being released in abortions and vaginal fluids. These problems are accentuated by the RB51 virulence in humans, lack diagnostic serological tests detecting these infections and RB51 rifampicin resistance. In controlled experiments, protection by RB51 compares unfavorably with S19 and lasts less than four years with no evidence that RB51-revaccination bolsters immunity, and field studies reporting its usefulness are flawed. There is no evidence that RB51 protects cattle against\n                    <jats:italic>B. melitensis,<\/jats:italic>\n                    infection common when raised together with small ruminants. Finally, data acumulated during cattle brucellosis eradication in Spain shows that S19-T\/S is far more efficacious than RB51-T\/S, which does not differ from T\/S alone. We conclude that the assumption that RB51 is DIVA, safe, and efficaceous results from the uncritical repetition of imperfectly examined evidence, and advise against its use.\n                  <\/jats:p>","DOI":"10.1186\/s12917-023-03773-3","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T02:02:19Z","timestamp":1697594539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: myths and facts"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6112-5312","authenticated-orcid":false,"given":"J. M.","family":"Blasco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8771-3959","authenticated-orcid":false,"given":"E.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-4929","authenticated-orcid":false,"given":"P. M.","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0046-3577","authenticated-orcid":false,"given":"R.","family":"Conde-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4288-0195","authenticated-orcid":false,"given":"I.","family":"Moriy\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"3773_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/pathogens11030377","volume":"11","author":"E Moreno","year":"2022","unstructured":"Moreno E, Letesson JJ, Gorvel JP, Moriy\u00f3n I. Pathogenicity and its implications in Taxonomy: The Brucella and Ochrobactrum case. Pathogens. 2022;11:377. https:\/\/doi.org\/10.3390\/pathogens11030377.","journal-title":"Pathogens"},{"key":"3773_CR2","unstructured":"OIE. Brucellosis (Infection with B. abortus, B. melitensis and B. suis). OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.1.4. Paris: OIE; 2022. p. 1\u201348."},{"key":"3773_CR3","doi-asserted-by":"publisher","first-page":"104865","DOI":"10.1016\/j.meegid.2021.104865","volume":"92","author":"AM Whatmore","year":"2021","unstructured":"Whatmore AM, Foster JT. Emerging diversity and ongoing expansion of the genus Brucella. Infect Gen Evol. 2021;92:104865. https:\/\/doi.org\/10.1016\/j.meegid.2021.104865.","journal-title":"Infect Gen Evol"},{"key":"3773_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.cimid.2012.09.001","volume":"36","author":"J Godfroid","year":"2013","unstructured":"Godfroid J, Al Dahouk S, Pappas G, et al. A \u201cOne Health\u201d surveillance and control of brucellosis in developing countries: Moving away from improvisation. Comp Immunol Microbiol Infect Dis. 2013;36:241\u20138. https:\/\/doi.org\/10.1016\/j.cimid.2012.09.001.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"3773_CR5","first-page":"197","volume-title":"Brucella melitensis","author":"JMB Verger","year":"1985","unstructured":"Verger JM. B. melitensis infection of cattle. In: Verger JM, Plommet M, editors. Brucella melitensis. Dordrech, Holland: Martinus Nijhoff; 1985. p. 197\u2013203."},{"key":"3773_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0167-5877(05)80041-8","volume":"11","author":"MP de Jim\u00e9nezBag\u00fc\u00e9s","year":"1991","unstructured":"Jim\u00e9nez de Bag\u00fc\u00e9s MP, Mar\u00edn CM, Blasco JM. Effect of antibiotic therapy and strain-19 vaccination on the spread of Brucella melitensis within an infected dairy herd. Prev Vet Med. 1991;11:17\u201324.","journal-title":"Prev Vet Med"},{"key":"3773_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0378-1135(02)00250-X","volume":"90","author":"V Taleski","year":"2002","unstructured":"Taleski V, Zerva L, Kantardjiev T, et al. An overview of the epidemiology and epizootiology of brucellosis in selected countries of Central and Southeast Europe. Vet Microbiol. 2002;90:147\u201355.","journal-title":"Vet Microbiol"},{"key":"3773_CR8","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.rvsc.2010.05.028","volume":"90","author":"J \u00c1lvarez","year":"2011","unstructured":"\u00c1lvarez J, S\u00e1ez JL, Garc\u00eda N, et al. Management of an outbreak of brucellosis due to B melitensis in dairy cattle in Spain. Res Vet Science. 2011;90:208\u201311.","journal-title":"Res Vet Science"},{"key":"3773_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11250-011-9899-9","volume":"44","author":"EN Muendo","year":"2012","unstructured":"Muendo EN, Mbatha PM, Macharia J, et al. Infection of cattle in Kenya with Brucella abortus biovar 3 and Brucella melitensis biovar 1 genotypes. Trop Anim Health Prod. 2012;44:17\u201320. https:\/\/doi.org\/10.1007\/s11250-011-9899-9.","journal-title":"Trop Anim Health Prod"},{"key":"3773_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.15547\/bjvm.842","volume":"18","author":"A Al-Mariri","year":"2015","unstructured":"Al-Mariri A. Isolation of Brucella melitensis strains from Syrian bovine milk samples. Bulg J Vet Med. 2015;18:40\u20138. https:\/\/doi.org\/10.15547\/bjvm.842.","journal-title":"Bulg J Vet Med"},{"key":"3773_CR11","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1016\/j.vaccine.2016.10.011","volume":"34","author":"M Van Straten","year":"2016","unstructured":"Van Straten M, Bardenstein S, Keningswald G, Banai M. Brucella abortus S19 vaccine protects dairy cattle against natural infection with Brucella melitensis. Vaccine. 2016;34:5837\u20139.","journal-title":"Vaccine"},{"key":"3773_CR12","first-page":"668","volume":"182","author":"FB Kolo","year":"2018","unstructured":"Kolo FB, Fasina FO, Ledwaba B, et al. Isolation of Brucella melitensis from cattle in South Africa. Rev Argent Microbiol. 2018;182:668\u20139.","journal-title":"Rev Argent Microbiol"},{"key":"3773_CR13","doi-asserted-by":"publisher","first-page":"e0213689","DOI":"10.1371\/journal.pone.0213689","volume":"14","author":"F De Massis","year":"2019","unstructured":"De Massis F, Zilli K, Donato GD, et al. Distribution of Brucella field strains isolated from livestock, wildlife populations, and humans in Italy from 2007 to 2015. PLoS One. 2019;14:e0213689. https:\/\/doi.org\/10.1371\/journal.pone.0213689.","journal-title":"PLoS One"},{"key":"3773_CR14","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3390\/PATHOGENS9060498","volume":"9","author":"G Wareth","year":"2020","unstructured":"Wareth G, El-Diasty M, Melzer F, et al. MLVA-16 Genotyping of Brucella abortus and Brucella melitensis isolates from different animal species in Egypt: Geographical relatedness and the Mediterranean lineage. Pathogens. 2020;9:498. https:\/\/doi.org\/10.3390\/PATHOGENS9060498.","journal-title":"Pathogens"},{"key":"3773_CR15","doi-asserted-by":"publisher","first-page":"001014","DOI":"10.1099\/mgen.0.001014","volume":"9","author":"S Bardenstein","year":"2023","unstructured":"Bardenstein S, Grupel D, Blum SE, Motro Y, Moran-Gilad J. Public and animal health risks associated with spillover of Brucella melitensis into dairy farms. Microb Genom. 2023;9:001014. https:\/\/doi.org\/10.1099\/mgen.0.001014.","journal-title":"Microb Genom"},{"key":"3773_CR16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3201\/eid0302.970219","volume":"3","author":"MJ Corbel","year":"1997","unstructured":"Corbel MJ. Brucellosis: an overview. Emerg Infect Dis. 1997;3:213\u201321.","journal-title":"Emerg Infect Dis"},{"key":"3773_CR17","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/104063879700900414","volume":"9","author":"DR Ewalt","year":"1997","unstructured":"Ewalt DR, Payeur JB, Rhyan JC, Geer PL. Brucella suis biovar 1 in naturally infected cattle: a bacteriological, serological, and histological study. J Vet Diagn Invest. 1997;9:417\u201320. https:\/\/doi.org\/10.1177\/104063879700900414.","journal-title":"J Vet Diagn Invest"},{"key":"3773_CR18","first-page":"672","volume":"20","author":"K Szulowski","year":"2013","unstructured":"Szulowski K, Iwaniak W, Weiner M, Z\u0142otnicka JJ. Brucella suis biovar 2 isolations from cattle in Poland. Ann Agr Env Med. 2013;20:672\u20135.","journal-title":"Ann Agr Env Med"},{"key":"3773_CR19","first-page":"125","volume":"10","author":"J Ariza","year":"1999","unstructured":"Ariza J. Brucellosis: an update. The perspective from the Mediterranean basin. Rev Med Microbiol. 1999;10:125\u201335.","journal-title":"Rev Med Microbiol"},{"key":"3773_CR20","unstructured":"Beeching NJ, Erdem H. Brucellosis. In: Farrar J, Hotez P, Junghanss T, Kang G, Lalloo D, White NJ, editors. Manson\u2019s Tropical Diseases. SECTION 6 International Medicine: Major Tropical Syndromes: Systemic Infections. Elsevier Health Sciences; 2016. p. 1098\u20131101."},{"key":"3773_CR21","volume-title":"Brucellosis in humans and animals","author":"MJ Corbel","year":"2006","unstructured":"Corbel MJ, Alton GG, Banai M, et al. Brucellosis in humans and animals. Geneva, Switzerland: WHO Press; 2006."},{"key":"3773_CR22","first-page":"89","volume":"111","author":"H Baggerud","year":"1947","unstructured":"Baggerud H. Combating brucellosis in Norway. J Am Vet Med Assoc. 1947;111:89\u201397.","journal-title":"J Am Vet Med Assoc"},{"key":"3773_CR23","first-page":"197","volume":"3","author":"A Thomsen","year":"1957","unstructured":"Thomsen A. Eradication of brucellosis in Scandinavia. Adv Vet Sci. 1957;3:197\u2013240.","journal-title":"Adv Vet Sci"},{"key":"3773_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.vetimm.2016.02.002","volume":"171","author":"MJ Ducrotoy","year":"2016","unstructured":"Ducrotoy MJ, Conde-\u00c1lvarez R, Blasco JM, Moriy\u00f3n I. A review of the basis of the immunological diagnosis of ruminant brucellosis. Vet Immunol Immunopathol. 2016;171:81\u2013102. https:\/\/doi.org\/10.1016\/j.vetimm.2016.02.002.","journal-title":"Vet Immunol Immunopathol"},{"key":"3773_CR25","doi-asserted-by":"crossref","unstructured":"Blasco JM, Moreno E, Moriy\u00f3n I. Brucellosis vaccines and vaccine candidates. In: Metwally S, Viljoen GJ, El Idrissi A, editors. Veterinary vaccines. Principles and applications. First Edition. Rome, Italy; Hobeken, USA: FAO and Wiley & Sons; 2021. p. 295\u2013316.","DOI":"10.1002\/9781119506287.ch22"},{"key":"3773_CR26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cvfa.2010.10.003","volume":"27","author":"JM Blasco","year":"2011","unstructured":"Blasco JM, Molina-Flores B. Control and eradication of Brucella melitensis infection in sheep and goats. Vet Clin North Am Food Anim Pract. 2011;27:95\u2013104.","journal-title":"Vet Clin North Am Food Anim Pract"},{"key":"3773_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.prevetmed.2018.01.005","volume":"151","author":"MJ Ducrotoy","year":"2018","unstructured":"Ducrotoy MJ, Mu\u00f1oz PM, Conde-\u00c1lvarez R, Blasco JM, Moriy\u00f3n I. A systematic review of current immunological tests for the diagnosis of cattle brucellosis. Prev Vet Med. 2018;151:57\u201372. https:\/\/doi.org\/10.1016\/j.prevetmed.2018.01.005.","journal-title":"Prev Vet Med"},{"key":"3773_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/microorganisms10050942","volume":"10","author":"E Moreno","year":"2022","unstructured":"Moreno E, Blasco JM, Moriy\u00f3n I. Facing the human and animal brucellosis conundrums: the forgotten lessons. Microorganisms. 2022;10:942. https:\/\/doi.org\/10.3390\/microorganisms10050942.","journal-title":"Microorganisms"},{"key":"3773_CR29","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0378-1135(02)00255-9","volume":"90","author":"G Schurig","year":"2002","unstructured":"Schurig G, Sriranganathan N, Corbel MJ. Brucellosis vaccines: past, present and future. Vet Microbiol. 2002;90:479\u201396.","journal-title":"Vet Microbiol"},{"key":"3773_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2003037","volume":"35","author":"I Moriy\u00f3n","year":"2004","unstructured":"Moriy\u00f3n I, Grill\u00f3 MJ, Monreal D, et al. Rough vaccines in animal brucellosis: structural and genetic basis and present status. Vet Res. 2004;35:1\u201338.","journal-title":"Vet Res"},{"key":"3773_CR31","doi-asserted-by":"crossref","first-page":"e2760","DOI":"10.1371\/journal.pone.0002760","volume":"3","author":"D Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez D, Grill\u00f3 MJ, de Miguel MJ, et al. Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export. PLoS One. 2008;3:e2760.","journal-title":"PLoS One"},{"key":"3773_CR32","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1534\/g3.119.400964","volume":"10","author":"B Bricker","year":"2020","unstructured":"Bricker B, Goonesekere N, Bayles D, Alt D, Olsen S, Vrentas C. Genome Report-A genome sequence analysis of the RB51 strain of Brucella abortus in the context of its vaccine properties. G3 (Bethesda, Md). 2020;10:1175\u201381. https:\/\/doi.org\/10.1534\/g3.119.400964.","journal-title":"G3 (Bethesda, Md)"},{"key":"3773_CR33","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/S0264-410X(02)00035-X","volume":"20","author":"A Cloeckaert","year":"2002","unstructured":"Cloeckaert A, Zygmunt MS, Guilloteau LA. Brucella abortus vaccine strain RB51 produces low levels of M-like O-antigen. Vaccine. 2002;20:1820\u20132.","journal-title":"Vaccine"},{"key":"3773_CR34","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.1128\/IAI.71.6.3261-3271.2003","volume":"71","author":"D Monreal","year":"2003","unstructured":"Monreal D, Grill\u00f3 MJ, Gonz\u00e1lez D, et al. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Infect Immun. 2003;71:3261\u201371. https:\/\/doi.org\/10.1128\/IAI.71.6.3261-3271.2003.","journal-title":"Infect Immun"},{"key":"3773_CR35","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1371\/journal.pmed.0040317","volume":"4","author":"J Ariza","year":"2007","unstructured":"Ariza J, Bosilkovski M, Cascio A, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 2007;4:e317.","journal-title":"PLoS Med"},{"key":"3773_CR36","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/IAI.73.7.4198-4204.2005","volume":"73","author":"R Adone","year":"2005","unstructured":"Adone R, Ciuchini F, Marianelli C, et al. Protective properties of rifampin-resistant rough mutants of Brucella melitensis. Infect Immun. 2005;73:4198\u2013204.","journal-title":"Infect Immun"},{"key":"3773_CR37","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/JCM.00837-08","volume":"46","author":"I L\u00f3pez-Go\u00f1i","year":"2008","unstructured":"L\u00f3pez-Go\u00f1i I, Garc\u00eda-Yoldi D, Mar\u00edn CM, et al. Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all Brucella species, including the vaccine strains. J Clin Microbiol. 2008;46:3484\u20137.","journal-title":"J Clin Microbiol"},{"key":"3773_CR38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-1135(00)00149-8","volume":"73","author":"RL Hornsby","year":"2000","unstructured":"Hornsby RL, Jensen AE, Olsen SC, Thoen CO. Selective media for isolation of Brucella abortus strain RB51. Vet Microbiol. 2000;73:51\u201360.","journal-title":"Vet Microbiol"},{"key":"3773_CR39","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1128\/JCM.02301-10","volume":"49","author":"MJ de Miguel","year":"2011","unstructured":"de Miguel MJ, Mar\u00edn CM, Mu\u00f1oz PM, Dieste-P\u00e9rez L, Grill\u00f3 MJ, Blasco JM. Development of a selective culture medium for primary isolation of the main Brucella species. J Clin Microbiol. 2011;49:1458\u201363.","journal-title":"J Clin Microbiol"},{"key":"3773_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0378-1135(91)90091-S","volume":"28","author":"G Schurig","year":"1991","unstructured":"Schurig G, Roop MR, Bagchi T, Boyle SM, Buhrman D, Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol. 1991;28:171\u201388. https:\/\/doi.org\/10.1016\/0378-1135(91)90091-S.","journal-title":"Vet Microbiol"},{"key":"3773_CR41","unstructured":"Colorado-Serum-Company. Brucella abortus vaccine strain RB-51 receives full licensing. 2003. http:\/\/www.thepeakofquality.com\/2003\/09\/02\/brucella-abortus-vaccine-strain-rb-51-receives-full-licensing. Accessed 9 Aug 2023."},{"key":"3773_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-1135(02)00240-7","volume":"90","author":"VE Ragan","year":"2002","unstructured":"Ragan VE. The Animal and Plant Health Inspection Service (APHIS) brucellosis eradication program in the United States. Vet Microbiol. 2002;90:11\u20138.","journal-title":"Vet Microbiol"},{"key":"3773_CR43","first-page":"19","volume":"27","author":"G Schurig","year":"1995","unstructured":"Schurig G, Boyle SM, Sriranganathan N. Brucella abortus vaccine strain RB51: a brief review. Arch Med Vet. 1995;27:19\u201322.","journal-title":"Arch Med Vet"},{"key":"3773_CR44","first-page":"1","volume":"3","author":"G Schurig","year":"2001","unstructured":"Schurig G. Uso de la vacuna RB51 contra brucelosis; diez preguntas a su creador el Dr. Gerhardt Schurig. Taurus BsAs. 2001;3:1\u20134.","journal-title":"Taurus BsAs"},{"key":"3773_CR45","unstructured":"USDA. Brucellosis eradication: Uniform methods and rules, effective October 1, 2003. 2003. https:\/\/www.aphis.usda.gov\/aphis\/ourfocus\/animalhealth\/animal-disease-information\/cattle-disease-information\/national-brucellosis-eradication\/brucellosis-eradication-program. Accessed 14 Dec 2022."},{"key":"3773_CR46","doi-asserted-by":"publisher","unstructured":"USDA. Brucella abortus strain RB51 vaccine licensed for use in cattle (Cattle Health Staff). Aphis Info Sheet. 2018. https:\/\/doi.org\/10.1128\/CVI.00326-10.2.","DOI":"10.1128\/CVI.00326-10.2"},{"key":"3773_CR47","unstructured":"USAHA. Committee on Cattle and Bison. Resolution number 35: continued use of RB51 vaccine. Kansas City, MO. 2018. http:\/\/www.usaha.org\/upload\/Resolution\/2018\/Resolution_35_Use_of_RB51_Vacc.pdf. Accessed 14 Dec 2022."},{"key":"3773_CR48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0378-1135(02)00241-9","volume":"90","author":"JE Luna-Mart\u00ednez","year":"2002","unstructured":"Luna-Mart\u00ednez JE, Mej\u00eda-Ter\u00e1n C. Brucellosis in Mexico: current status and trends. Vet Microbiol. 2002;90:19\u201330.","journal-title":"Vet Microbiol"},{"key":"3773_CR49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0167-5877(00)00130-6","volume":"45","author":"LE Samartino","year":"2000","unstructured":"Samartino LE, Fort M, Gregoret R, Schurig G. Use of Brucella abortus vaccine strain RB51 in pregnant cows after calfhood vaccination with strain 19 in Argentina. Prev Vet Med. 2000;45:193\u20139.","journal-title":"Prev Vet Med"},{"key":"3773_CR50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1006468713614","volume":"24","author":"FA Uzal","year":"2000","unstructured":"Uzal FA, Samartino LE, Schurig G, et al. Effect of vaccination with Brucella abortus strain RB51 on heifers and pregnant cattle. Vet Res Commun. 2000;24:143\u201351.","journal-title":"Vet Res Commun"},{"key":"3773_CR51","unstructured":"PNCBT-Brazil. Instru\u00e7\u00e3o normativa n\u00ba 10, de 3 de mar\u00e7o de 2017. Bras\u00edlia. Di\u00e1rio Oficial da Uni\u00e3o: Distrito Federal Brasil\u00eda. 2017;16 Se\u00e7\u00e3o 1:4\u20138."},{"key":"3773_CR52","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1111\/tbed.13797","volume":"68","author":"C Rodrigues Pereira","year":"2021","unstructured":"Rodrigues Pereira C, de Cardoso Oliveira IR, de Faria Oliveira L, de Fonseca Oliveira CS, Pereira Lage A, Dorneles EMS. Accidental exposure to Brucella abortus vaccines and occupational brucellosis among veterinarians in Minas Gerais state, Brazil. Transbound Emerg Dis. 2021;68:1363\u201376. https:\/\/doi.org\/10.1111\/tbed.13797.","journal-title":"Transbound Emerg Dis"},{"key":"3773_CR53","unstructured":"MSD Animal Health. RB51. 2022. https:\/\/www.msd-animal-health.co.za\/products\/rb-51. Accessed 6 Jul 2023."},{"key":"3773_CR54","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/vr.101979","volume":"174","author":"JL S\u00e1ez","year":"2014","unstructured":"S\u00e1ez JL, Sanz C, Dur\u00e1n-Ferrer M, et al. Comparison of depopulation and S19-RB51 vaccination strategies for control of bovine brucellosis in high prevalence areas. Vet Rec. 2014;174:634. https:\/\/doi.org\/10.1136\/vr.101979.","journal-title":"Vet Rec"},{"key":"3773_CR55","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1016\/j.vaccine.2015.05.057","volume":"33","author":"EMS Dorneles","year":"2015","unstructured":"Dorneles EMS, Teixeira-Carvalho A, Ara\u00fajo MSS, Sriranganathan N, Lage AP. Immune response triggered by Brucella abortus following infection or vaccination. Vaccine. 2015;33:3659\u201366.","journal-title":"Vaccine"},{"key":"3773_CR56","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1586\/14760584.4.6.915","volume":"4","author":"SC Olsen","year":"2005","unstructured":"Olsen SC, Stoffregen WS. Essential role of vaccines in brucellosis control and eradication programs for livestock. Expert Rev Vaccines. 2005;4:915\u201328.","journal-title":"Expert Rev Vaccines"},{"key":"3773_CR57","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vetimm.2008.09.007","volume":"127","author":"CA Robles","year":"2009","unstructured":"Robles CA, Nielsen KH, Gall D, Willems P. Evaluation of three different antigens in an indirect enzyme-linked immunoassay for the detection of antibodies against Brucella abortus SRB51 in vaccinated heifers. Vet Immunol Immunopathol. 2009;127:153\u20135.","journal-title":"Vet Immunol Immunopathol"},{"key":"3773_CR58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4067\/S0301-732X1998000200011","volume":"30","author":"NI Monta\u00f1a","year":"1998","unstructured":"Monta\u00f1a NI, Rueda OE, Calder\u00f3n CP, et al. Medici\u00f3n de respuesta inmune humoral y celular frente a ant\u00edgenos de Brucella abortus RB51 en bovinos. Arch Vet Med. 1998;30:109\u201323.","journal-title":"Arch Vet Med"},{"key":"3773_CR59","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13567-014-0139-y","volume":"46","author":"EMS Dorneles","year":"2015","unstructured":"Dorneles EMS, Sriranganathan N, Lage AP. Recent advances in Brucella abortus vaccines. Vet Res. 2015;46:19.","journal-title":"Vet Res"},{"key":"3773_CR60","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1016\/j.vaccine.2019.05.084","volume":"37","author":"H Hou","year":"2019","unstructured":"Hou H, Liu X, Peng Q. The advances in brucellosis vaccines. Vaccine. 2019;37:3981\u20138. https:\/\/doi.org\/10.1016\/j.vaccine.2019.05.084.","journal-title":"Vaccine"},{"key":"3773_CR61","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1016\/j.vaccine.2006.04.020","volume":"24","author":"F Padilla Poester","year":"2006","unstructured":"Padilla Poester F, Gon\u00e7alves VSPP, Paix\u00e3o TA, et al. Efficacy of strain RB51 vaccine in heifers against experimental brucellosis. Vaccine. 2006;24:5327\u201334. https:\/\/doi.org\/10.1016\/j.vaccine.2006.04.020.","journal-title":"Vaccine"},{"key":"3773_CR62","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2460\/ajvr.1996.57.08.1153","volume":"57","author":"NF Cheville","year":"1996","unstructured":"Cheville NF, Olsen SC, Jensen AE, Stevens MG, Palmer MV, Florance AM. Effects of age at vaccination on efficacy of Brucella abortus strain RB51 to protect cattle against brucellosis. Am J Vet Res. 1996;57:1153\u20136.","journal-title":"Am J Vet Res"},{"key":"3773_CR63","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1053\/rvsc.1998.0251","volume":"66","author":"SC Olsen","year":"1999","unstructured":"Olsen SC, Bricker BJ, Palmer MV, Jensen AE, Cheville NF. Responses of cattle to two dosages of Brucella abortus strain RB51: serology, clearance and efficacy. Res Vet Science. 1999;66:101\u20135. https:\/\/doi.org\/10.1053\/rvsc.1998.0251.","journal-title":"Res Vet Science"},{"key":"3773_CR64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/rvsc.2000.0405","volume":"69","author":"SC Olsen","year":"2000","unstructured":"Olsen SC. Responses of adult cattle to vaccination with a reduced dose of Brucella abortus strain RB51. Res Vet Science. 2000;69:135\u201340.","journal-title":"Res Vet Science"},{"key":"3773_CR65","doi-asserted-by":"publisher","first-page":"105705","DOI":"10.1016\/j.prevetmed.2022.105705","volume":"206","author":"SC Olsen","year":"2022","unstructured":"Olsen SC, Boggiatto PM. Characterization of the duration of immunity of Brucella abortus strain RB51 vaccination in cattle after experimental challenge. Prev Vet Med. 2022;206:105705. https:\/\/doi.org\/10.1016\/j.prevetmed.2022.105705.","journal-title":"Prev Vet Med"},{"key":"3773_CR66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cimid.2004.07.003","volume":"28","author":"M Leal-Hern\u00e1ndez","year":"2005","unstructured":"Leal-Hern\u00e1ndez M, D\u00edaz-Aparicio E, P\u00e9rez R, et al. Protection of Brucella abortus RB51 revaccinated cows, introduced in a herd with active brucellosis, with presence of atypical humoral response. Comp Immunol Microbiol Infect Dis. 2005;28:63\u201370.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"3773_CR67","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1128\/CVI.00326-10","volume":"17","author":"SC Olsen","year":"2010","unstructured":"Olsen SC, Hennager SG. Immune responses and protection against experimental Brucella suis biovar 1 challenge in non-vaccinated or B. abortus strain RB51-vaccinated cattle. Clin Vaccine Immunol. 2010;17:1891\u20135.","journal-title":"Clin Vaccine Immunol."},{"key":"3773_CR68","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/104063879600800408","volume":"8","author":"SC Olsen","year":"1996","unstructured":"Olsen SC, Evans D, Hennager SG, Cheville NF, Stevens MG. Serologic responses of Brucella abortus strain 19 calfhood-vaccinated cattle following adult vaccination with strain RB51. J Vet Diagn Invest. 1996;8:451\u20134.","journal-title":"J Vet Diagn Invest"},{"key":"3773_CR69","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/0923-2508(96)80563-8","volume":"146","author":"E Freer","year":"1995","unstructured":"Freer E, Rojas N, Weintraub A, Lindberg AA, Moreno E. Heterogeneity of Brucella abortus lipopolysaccharides. Res Microbiol. 1995;146:569\u201378. https:\/\/doi.org\/10.1016\/0923-2508(96)80563-8.","journal-title":"Res Microbiol"},{"key":"3773_CR70","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1128\/IAI.68.6.3210-3218.2000","volume":"68","author":"J Velasco","year":"2000","unstructured":"Velasco J, Bengoechea JA, Brandenburg K, et al. Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance. Infect Immun. 2000;68:3210\u20138. https:\/\/doi.org\/10.1128\/IAI.68.6.3210-3218.2000.","journal-title":"Infect Immun"},{"key":"3773_CR71","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2460\/ajvr.1993.54.10.1591","volume":"54","author":"NF Cheville","year":"1993","unstructured":"Cheville NF, Stevens MG, Jensen AE, Tatum FM, Halling SM. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am J Vet Res. 1993;54:1591\u20137.","journal-title":"Am J Vet Res"},{"key":"3773_CR72","doi-asserted-by":"publisher","first-page":"104345","DOI":"10.1016\/j.micpath.2020.104345","volume":"147","author":"AR Faria","year":"2020","unstructured":"Faria AR, Dorneles EMS, Pires SDF, Andrade HMD, Lage AP. Immunoproteomics of Brucella abortus reveals potential of recombinant antigens for discriminating vaccinated from naturally infected cattle. Microb Pathog. 2020;147:104345. https:\/\/doi.org\/10.1016\/j.micpath.2020.104345.","journal-title":"Microb Pathog"},{"key":"3773_CR73","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.20506\/rst.24.3.1628","volume":"24","author":"KH Nielsen","year":"2005","unstructured":"Nielsen KH, Smith P, Yu W, et al. Towards single screening tests for brucellosis. Rev Sci Tech Off Int Epiz. 2005;24:1027\u201337.","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"3773_CR74","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1439-0450.2001.00476.x","volume":"48","author":"N Rojas","year":"2001","unstructured":"Rojas N, Zamora O, Cascante J, Garita D, Moreno E. Comparison of the antibody response in adult cattle against different epitopes of Brucella abortus lipopolysaccharide. J Vet Med, series B. 2001;48:623\u20139.","journal-title":"J Vet Med, series B"},{"key":"3773_CR75","first-page":"61","volume":"37","author":"F Padilla Poester","year":"2000","unstructured":"Padilla Poester F, Ramos ET, Gomes MJP, Chiminazzo C, Schurig G. The serological response of adult cattle after vaccination with Brucella abortus strain 19 and RB51. Braz J Vet Res Anim Sci. 2000;37:61\u20134.","journal-title":"Braz J Vet Res Anim Sci"},{"key":"3773_CR76","doi-asserted-by":"crossref","first-page":"e0007509","DOI":"10.1371\/journal.pntd.0007509","volume":"13","author":"AM Gusi","year":"2019","unstructured":"Gusi AM, Bertu WJ, de Miguel MJ, et al. Comparative performance of lateral flow immunochromatography, iELISA and Rose Bengal tests for the diagnosis of cattle, sheep, goat and swine brucellosis. PLoS Negl Trop Dis. 2019;13:e0007509.","journal-title":"PLoS Negl Trop Dis"},{"key":"3773_CR77","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/j.vaccine.2009.01.025","volume":"27","author":"MB Barrio","year":"2009","unstructured":"Barrio MB, Grill\u00f3 MJ, Mu\u00f1oz PM, et al. Rough mutants defective in core and O-polysaccharide synthesis and export induce antibodies reacting in an indirect ELISA with smooth lipopolysaccharide and are less effective than Rev 1 vaccine against Brucella melitensis infection of sheep. Vaccine. 2009;27:1741\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2009.01.025.","journal-title":"Vaccine"},{"key":"3773_CR78","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/1040638720970888","volume":"33","author":"SC Olsen","year":"2021","unstructured":"Olsen SC, Crawford LS, Fuentes A, Kostovic M, Boggiatto PM. Influence of species of negative control sera on results of a brucellosis fluorescence polarization assay. J Vet Diagn Invest. 2021;33:67\u201372. https:\/\/doi.org\/10.1177\/1040638720970888.","journal-title":"J Vet Diagn Invest"},{"key":"3773_CR79","unstructured":"Jacobson RH. Principles of validation of diagnostic assays for infectious diseases. Manual of standards for diagnostic tests and vaccines, 3rd ed. Paris: Office International de Epizooties. 1996. p. 8\u201315."},{"key":"3773_CR80","doi-asserted-by":"publisher","first-page":"469","DOI":"10.20506\/rst.17.2.1119","volume":"17","author":"RH Jacobson","year":"1998","unstructured":"Jacobson RH. Validation of serological assays for diagnosis of infectious diseases. Rev Sci Tech Off Int Epiz. 1998;17:469\u2013526. https:\/\/doi.org\/10.20506\/rst.17.2.1119.","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"3773_CR81","unstructured":"Tribunal Superior de Justicia de Castilla Le\u00f3n, Spain. SENTENCIA 00695\/2015. 2020. https:\/\/www.poderjudicial.es\/search\/AN\/openDocument\/5adeee1d57461004\/20150527. Accessed 14 December 2022."},{"key":"3773_CR82","volume-title":"Techniques for the brucellosis laboratory","author":"GG Alton","year":"1988","unstructured":"Alton GG, Jones LM, Angus RD, Verger JM. Techniques for the brucellosis laboratory. Paris, France: INRA; 1988."},{"key":"3773_CR83","first-page":"283","volume-title":"Animal Brucellosis","author":"NP Vaccination","year":"1990","unstructured":"Nicoletti, P. \u00a0Vaccination. In: Nielsen KH, Duncan JR, editors. Animal Brucellosis. Boca Raton: CRC Press; 1990. p. 283\u201399."},{"key":"3773_CR84","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/030098589603300607","volume":"33","author":"MV Palmer","year":"1996","unstructured":"Palmer MV, Cheville NF, Jensen AE. Experimental infection of pregnant cattle with the vaccine candidate Brucella abortus strain RB51: pathologic, bacteriologic, and serologic findings. Vet Pathol. 1996;33:682\u201391.","journal-title":"Vet Pathol"},{"key":"3773_CR85","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2460\/ajvr.1997.58.05.472","volume":"58","author":"MV Palmer","year":"1997","unstructured":"Palmer MV, Olsen SC, Cheville NF. Safety and immunogenicity of Brucella abortus strain RB51 vaccine in pregnant cattle. Am J Vet Res. 1997;58:472\u20137.","journal-title":"Am J Vet Res"},{"key":"3773_CR86","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2460\/ajvr.1999.60.06.722","volume":"60","author":"MD Edmonds","year":"1999","unstructured":"Edmonds MD, Schurig G, Samartino LE, et al. Biosafety of Brucella abortus strain RB51 for vaccination of mature bulls and pregnant heifers. Am J Vet Res. 1999;60:722\u20135.","journal-title":"Am J Vet Res"},{"key":"3773_CR87","unstructured":"Barbosa AA, Fernandes CAC, Figueiredo ACS et al. Brucella abortus rough strain vaccine is safe for cows at different stages of pregnancy. Proc 28th Ann Meet Brazilian Embryo Tech Soc (SBTE), August 14 to 17th, 2014, Natal, RN, Brazil. 2014"},{"key":"3773_CR88","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s11250-017-1361-1","volume":"49","author":"AA Barbosa","year":"2017","unstructured":"Barbosa AA, Figueiredo ACS, Palhao MP, Viana JHM, Fernandes CAC. Safety of vaccination against brucellosis with the rough strain in pregnant cattle. Trop Anim Health Prod. 2017;49:1779\u201381.","journal-title":"Trop Anim Health Prod"},{"key":"3773_CR89","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.prevetmed.2009.04.002","volume":"90","author":"H Martins","year":"2009","unstructured":"Martins H, Garin-Bastuji B, Lima F, Flor L, Pina Fonseca A, Boinas F. Eradication of bovine brucellosis in the Azores, Portugal\u2014Outcome of a 5-year programme (2002\u20132007) based on test-and-slaughter and RB51 vaccination. Prev Vet Med. 2009;90:80\u20139.","journal-title":"Prev Vet Med"},{"key":"3773_CR90","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.prevetmed.2009.10.009","volume":"94","author":"JM Blasco","year":"2010","unstructured":"Blasco JM, Moriy\u00f3n I. Letter to the Editor. Eradication of bovine brucellosis in the Azores, Portugal\u2014Outcome of a 5-year programme (2002\u20132007) based on test-and-slaughter and RB51 vaccination. Prev Vet Med. 2010;94:154\u20137.","journal-title":"Prev Vet Med"},{"key":"3773_CR91","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.3390\/microorganisms11082070","volume":"11","author":"I Moriy\u00f3n","year":"2023","unstructured":"Moriy\u00f3n I, Blasco JM, Letesson JJ, De Massis F, Moreno E. Brucellosis and One Health: inherited and future challenges. Microorganisms. 2023;11:2070. https:\/\/doi.org\/10.3390\/microorganisms11082070.","journal-title":"Microorganisms"},{"key":"3773_CR92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.prevetmed.2010.08.003","volume":"97","author":"C Sanz","year":"2010","unstructured":"Sanz C, S\u00e1ez JL, \u00c1lvarez J, et al. Mass vaccination as a complementary tool in the control of a severe outbreak of bovine brucellosis due to Brucella abortus in Extremadura. Spain Prev Vet Med. 2010;97:119\u201325.","journal-title":"Spain Prev Vet Med"},{"key":"3773_CR93","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1111\/tbed.12228","volume":"63","author":"MC Caetano","year":"2014","unstructured":"Caetano MC, Afonso F, Ribeiro R, Fonseca AP, Abernethy DA, Boinas F. Control of bovine brucellosis from persistently infected holdings using RB51 vaccination with test-and-slaughter: a comparative case report from a high incidence area in Portugal. Transbound Emerg Dis. 2014;63:e39\u201347.","journal-title":"Transbound Emerg Dis"},{"key":"3773_CR94","unstructured":"OIE. Bovine brucellosis. OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 2.3.1. Paris: OIE; 2004. p. 1\u201331."},{"key":"3773_CR95","unstructured":"CZ Vaccines. RB-51 CZV. Ficha t\u00e9cnica o resumen de las caracter\u00edsticas del producto. 2023. https:\/\/preventingwithexperts.com\/disease\/brucellosis\/. Accessed 3 Aug 2023."},{"key":"3773_CR96","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4142\/jvs.2014.15.4.537","volume":"15","author":"H Yoon","year":"2014","unstructured":"Yoon H, Moon OK, Lee SH, et al. Epidemiology of brucellosis among cattle in Korea from 2001 to 2011. J Vet Sci. 2014;15:537\u201343. https:\/\/doi.org\/10.4142\/jvs.2014.15.4.537.","journal-title":"J Vet Sci"},{"key":"3773_CR97","unstructured":"Lopetegui P. Erradicaci\u00f3n de brucelosis bovina en Chile. Experiencias en el uso de la vacuna cepa RB51. III Foro Nacional de brucelosis, Acapulco, M\u00e9xico, 20\u201321 July. 1998;1:159\u2013157."},{"key":"3773_CR98","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2460\/javma.1999.215.10.1491","volume":"215","author":"DC Van Metre","year":"1999","unstructured":"Van Metre DC, Kennedy GA, Olsen SC, Hansen GR, Ewalt DR. Brucellosis induced by RB51 vaccine in a pregnant heifer. J Am Vet Med Assoc. 1999;215:1491\u20133.","journal-title":"J Am Vet Med Assoc"},{"key":"3773_CR99","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/vr.165.19.570","volume":"165","author":"HS Yazdi","year":"2009","unstructured":"Yazdi HS, Kafi M, Haghkhah M, Tamadon A, Behroozikhah AM, Ghane M. Abortions in pregnant dairy cows after vaccination with Brucella abortus strain RB51. Vet Rec. 2009;165:570\u20131.","journal-title":"Vet Rec"},{"key":"3773_CR100","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1177\/1040638713499570","volume":"25","author":"AM Fluegel-Dougherty","year":"2013","unstructured":"Fluegel-Dougherty AM, Cornish TE, O\u2019Toole D, Boerger-Fields AM, Henderson OL, Mills KW. Abortion and premature birth in cattle following vaccination with Brucella abortus strain RB51. J Vet Diagn Invest. 2013;25:630\u20135.","journal-title":"J Vet Diagn Invest"},{"key":"3773_CR101","unstructured":"Mainar-Jaime RC, Mu\u00f1oz PM, De Miguel MJ, Mar\u00edn CM, Blasco JM. Abortions induced by RB51 vaccine in beef cattle in central Spain: a descriptive study. Brucellosis 2011 Int Res Conf, Buenos Aires, Argentina, September 21\u201323, 2011."},{"key":"3773_CR102","unstructured":"Mainar-Jaime RC, Mar\u00edn CM, de Miguel MJ, Mu\u00f1oz PM, Blasco JM. Experiences on the use of RB51 vaccine in Spain. Proc Brucellosis 2008 Int Conf, Royal Holloway College, University of London, UK. 200810-13"},{"key":"3773_CR103","unstructured":"Fiorentino MA, Campero CM, Carrin D et al. Vaccination in adult bulls with Brucella abortus RB51 and challenged with Brucella abortus 2308. 23rd World Buiatrics Congress, July 2004, Canada. 2004"},{"key":"3773_CR104","unstructured":"MSD Salud Animal. Bovilis RB51. Ficha T\u00e9cnica. 2023. https:\/\/www.msd-salud-animal.mx\/wp-content\/uploads\/sites\/43\/2021\/03\/Bovilis-RB51.pdf. Accessed 3 Aug 2023."},{"key":"3773_CR105","unstructured":"MSD Salud Animal Merck & Co. Inc. Vacuna RB51. 2022. https:\/\/www.soydelcampo.com\/vademecum\/veterinario\/VACUNA-RB51\/producto.php?id=6600#. Accessed 9 Aug 2023."},{"key":"3773_CR106","unstructured":"Colorado Serum Company. Brucella abortus Vaccine - Strain RB-51. 2023. https:\/\/colorado-serum-com.3dcartstores.com\/brucella. Accessed 5 Aug 2023."},{"key":"3773_CR107","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11250-012-0252-8","volume":"45","author":"B Arellano-Reynoso","year":"2012","unstructured":"Arellano-Reynoso B, Su\u00e1rez-Guemes F, Mej\u00eda Estrada F, et al. Isolation of a field strain of Brucella abortus from RB51-vaccinated- and brucellosis-seronegative bovine yearlings that calved normally. Trop Anim Health Prod. 2012;45:695\u20137. https:\/\/doi.org\/10.1007\/s11250-012-0252-8.","journal-title":"Trop Anim Health Prod"},{"key":"3773_CR108","first-page":"172","volume":"47","author":"CDC_(U.S.)","year":"1998","unstructured":"CDC (U.S.A.). Human exposure to Brucella abortus strain RB51--Kansas, 1997. Morb Mortal Wkly Rep. 1998;47:172\u20135.","journal-title":"Morb Mortal Wkly Rep"},{"key":"3773_CR109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4067\/S0301-732X2000000100011","volume":"32","author":"M Villarroel","year":"2000","unstructured":"Villarroel M, Grell M, Saenz R. Reporte de primer caso humano de aislamiento y tipificaci\u00f3n de Brucella abortus RB51. Arch Vet Med. 2000;32:89\u201391.","journal-title":"Arch Vet Med"},{"key":"3773_CR110","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.vaccine.2004.02.041","volume":"22","author":"DA Ashford","year":"2004","unstructured":"Ashford DA, di Pietra J, Lingappa J, et al. Adverse events in humans associated with accidental exposure to the livestock brucellosis vaccine RB51. Vaccine. 2004;22:3435\u20139.","journal-title":"Vaccine"},{"key":"3773_CR111","doi-asserted-by":"crossref","first-page":"747","DOI":"10.15585\/mmwr.mm6726a4","volume":"67","author":"SM Hatcher","year":"2018","unstructured":"Hatcher SM, Shih D, Holderman J, Cossaboom C, Leman R, DeBess E. Notes from the Field: Adverse event associated with unintentional exposure to the Brucella abortus RB51 vaccine - Oregon, December 2017. Morb Mortal Wkly Rep. 2018;67:747.","journal-title":"Morb Mortal Wkly Rep"},{"key":"3773_CR112","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/15245000500496636","volume":"68","author":"ME Negr\u00f3n","year":"2019","unstructured":"Negr\u00f3n ME, Kharod GA, Bower WA, Walke H. Notes from the field - Human Brucella abortus RB51 infections caused by consumption of unpasteurized domestic dairy products\u2014 United States, 2017\u20132019. Morb Mortal Wkly Rep. 2019;68:185. https:\/\/doi.org\/10.1080\/15245000500496636.","journal-title":"Morb Mortal Wkly Rep"},{"key":"3773_CR113","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1086\/375595","volume":"37","author":"LJ Strausbaugh","year":"2003","unstructured":"Strausbaugh LJ, Berkelman RL. Human illness associated with use of veterinary vaccines. Clin Infect Dis. 2003;37:407\u201314.","journal-title":"Clin Infect Dis"},{"key":"3773_CR114","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clinmicnews.2019.01.004","volume":"41","author":"M-A Rowlinson","year":"2019","unstructured":"Rowlinson M-A, Lee P. Brucella abortus RB51 strain sent in a proficiency testing panel to Clinical and Public Health laboratories. Clin Microbiol Newsl. 2019;41:23\u201332. https:\/\/doi.org\/10.1016\/j.clinmicnews.2019.01.004.","journal-title":"Clin Microbiol Newsl"},{"key":"3773_CR115","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1471-2180-14-186","volume":"14","author":"EM Dorneles","year":"2014","unstructured":"Dorneles EM, Santana JA, Alves TM, et al. Genetic stability of Brucella abortus isolates from an outbreak by multiple-locus variable-number tandem repeat analysis (MLVA16). BMC Microbiol. 2014;14:186.","journal-title":"BMC Microbiol"},{"key":"3773_CR116","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.actatropica.2016.04.012","volume":"160","author":"KL Miranda","year":"2016","unstructured":"Miranda KL, Poester FP, Dorneles EMS, et al. Brucella abortus RB51 in milk of vaccinated adult cattle. Acta Trop. 2016;160:58\u201361. https:\/\/doi.org\/10.1016\/j.actatropica.2016.04.012.","journal-title":"Acta Trop"},{"key":"3773_CR117","first-page":"104","volume":"99","author":"MV Palmer","year":"1995","unstructured":"Palmer MV, Olsen SC, Stevens MG, Cheville NF. Placentitis induced by Brucella abortus strain RB51 in pregnant cattle. Proc Ann Meet US Anim Health Assoc. 1995;99:104\u20137.","journal-title":"Proc Ann Meet US Anim Health Assoc"},{"key":"3773_CR118","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.4315\/0362-028X.JFP-18-186","volume":"81","author":"RW Currier","year":"2018","unstructured":"Currier RW, Widness JA. A brief history of milk hygiene and its impact on infant mortality from 1875 to 1925 and implications for today: A review. J Food Prot. 2018;81:1713\u201322.","journal-title":"J Food Prot"},{"key":"3773_CR119","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1542\/peds.2013-3502","volume":"133","author":"Committee-of-Infectious-Diseases-and-Committee-on-Nutrition","year":"2013","unstructured":"Committee of Infectious Diseases and Committee on Nutrition. Consumption of Raw or Unpasteurized Milk and Milk Products by Pregnant Women and Children (Policy Statement). Pediatrics. 2013;133:175\u20139. https:\/\/doi.org\/10.1542\/peds.2013-3502.","journal-title":"Pediatrics"},{"key":"3773_CR120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.15585\/mmwr.mm6709a4","volume":"67","author":"CM Cossaboom","year":"2018","unstructured":"Cossaboom CM, Kharod GA, Salzer JS, et al. Notes from the field: Brucella abortus vaccine strain RB51 infection and exposures associated with raw milk consumption - Wise County, Texas, 2017. Morb Mortal Wkly Rep. 2018;67:286.","journal-title":"Morb Mortal Wkly Rep"},{"key":"3773_CR121","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1099\/jmm.0.000722","volume":"67","author":"MM Sfeir","year":"2018","unstructured":"Sfeir MM. Raw milk intake: beware of emerging brucellosis. J Med Microbiol. 2018;67:681\u20132. https:\/\/doi.org\/10.1099\/jmm.0.000722.","journal-title":"J Med Microbiol"},{"key":"3773_CR122","unstructured":"Tiller R, Quance CR, Robbe-Austerman S et al. Brucella abortus RB51 vaccine strain and raw milk consumption: An emerging Public Health risk. Proc Brucellosis 2022 Int Res Conf including the 74th Brucellosis Res Conf; 2022. p. 59."},{"key":"3773_CR123","unstructured":"FDA. FDA alerts consumers about risk of antibiotic-resistant Brucella linked to raw milk from udder milk Co-Op. U.S. 2017. www.fda.gov\/Food\/RecallsOutbreaksEmergencies\/Outbreaks\/ucm585655.htm. Accessed 11 Dec 2022."},{"key":"3773_CR124","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1089\/fpd.2022.0001","volume":"8","author":"JC Ben\u00edtez-Serrano","year":"2022","unstructured":"Ben\u00edtez-Serrano JC, Palomares-Resendiz G, D\u00edaz-Aparicio E, et al. Survival of Brucella abortus RB51 and S19 vaccine strains in fresh and ripened cheeses. Foodborne Pathog Dis. 2022;8:535\u201342. https:\/\/doi.org\/10.1089\/fpd.2022.0001.","journal-title":"Foodborne Pathog Dis"},{"key":"3773_CR125","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1097\/INF.0000000000003200","volume":"40","author":"AS Clemente","year":"2021","unstructured":"Clemente AS, Amerson-Brown MH, Foster CE. An adolescent with neurobrucellosis caused by Brucella abortus cattle vaccine strain RB51. Pediatr Infect Dis J. 2021;40:e353\u20135.","journal-title":"Pediatr Infect Dis J"},{"key":"3773_CR126","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1297-9716-43-29","volume":"43","author":"MJ Grill\u00f3","year":"2012","unstructured":"Grill\u00f3 MJ, Blasco JM, Gorvel JP, Moriy\u00f3n I, Moreno E. What have we learned from brucellosis in the mouse model? Vet Res. 2012;43:29. https:\/\/doi.org\/10.1186\/1297-9716-43-29.","journal-title":"Vet Res"},{"key":"3773_CR127","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1111\/tbed.14440","volume":"69","author":"JM Blasco","year":"2022","unstructured":"Blasco JM, Moreno E, Moriy\u00f3n I. Efficacy of Brucella abortus S19 and RB51 vaccine strains: A systematic review and meta-analysis (Letter to the Editor). Transbound Emerg Dis. 2022;69:1670\u20133. https:\/\/doi.org\/10.1111\/tbed.14440.","journal-title":"Transbound Emerg Dis"},{"key":"3773_CR128","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.2460\/ajvr.1998.59.12.1575","volume":"59","author":"PH Elzer","year":"1998","unstructured":"Elzer PH, Enright FM, Colby L, et al. Protection against infection and abortion induced by virulent challenge exposure after oral vaccination of cattle with Brucella abortus strain RB51. Am J Vet Res. 1998;59:1575\u20138.","journal-title":"Am J Vet Res"},{"key":"3773_CR129","first-page":"183","volume":"3","author":"SC Olsen","year":"2000","unstructured":"Olsen SC. Immune responses and efficacy after administration of a commercial Brucella abortus RB51 vaccine to cattle. Vet Therap. 2000;3:183\u201391.","journal-title":"Vet Therap"},{"key":"3773_CR130","doi-asserted-by":"publisher","first-page":"5889","DOI":"10.1016\/j.vaccine.2014.08.073","volume":"32","author":"K Tabynov","year":"2014","unstructured":"Tabynov K, Yespembetov B, Sansyzbay A. Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7\/L12 or Omp16 proteins: Evaluation of protection in pregnant heifers. Vaccine. 2014;32:5889\u201392. https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.073.","journal-title":"Vaccine"},{"key":"3773_CR131","volume-title":"Prueba de eficacia de las vacunas antibruc\u00e9licas RB51 y cepa 19 en bovinos","author":"E Bagnat","year":"2002","unstructured":"Bagnat E, Maneti JC. Prueba de eficacia de las vacunas antibruc\u00e9licas RB51 y cepa 19 en bovinos. Argentina: Documento SENASA; 2000. p. 1\u201348."},{"key":"3773_CR132","first-page":"428","volume":"81","author":"E Bagnat","year":"2000","unstructured":"Bagnat E, Manetti JC. Prueba de eficacia de las vacunas antibruc\u00e9licas RB51 y cepa 19 en bovinos. Rev Med Vet - Buenos Aires. 2000;81:428\u20139.","journal-title":"Rev Med Vet - Buenos Aires"},{"key":"3773_CR133","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2460\/ajvr.1998.59.08.1016","volume":"59","author":"VR Lord","year":"1998","unstructured":"Lord VR, Schurig G, Cherwonogrodzky JW, Marcano MJ, Melendez GE. Field study of vaccination of cattle with Brucella abortus strains RB51 and 19 under high and low disease prevalence. Am J Vet Res. 1998;59:1016\u201320.","journal-title":"Am J Vet Res"},{"key":"3773_CR134","unstructured":"SAG. Brucelosis bovina (bb). Programa nacional de erradicaci\u00f3n de brucelosis bovina. Situaci\u00f3n actual. Ministerio de Agricultura de Chile. 2022. https:\/\/www.sag.gob.cl\/ambitos-de-accion\/brucelosis-bovina-bb. Accessed 9 Aug 2023."},{"key":"3773_CR135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1196\/annals.1428.011","volume":"1149","author":"E Herrera","year":"2008","unstructured":"Herrera E, Palomares G, D\u00edaz-Aparicio E. Milk production increase in a dairy farm under a six-year brucellosis control program. Ann N Y Acad Sci. 2008;1149:296\u20139.","journal-title":"Ann N Y Acad Sci"},{"key":"3773_CR136","doi-asserted-by":"crossref","first-page":"e0182380","DOI":"10.1371\/journal.pone.0182380","volume":"12","author":"G Hern\u00e1ndez-Mora","year":"2017","unstructured":"Hern\u00e1ndez-Mora G, Ruiz-Villalobos N, Bonilla-Montoya R, et al. Epidemiology of bovine brucellosis in Costa Rica: Lessons learned from failures in the control of the disease. PLoS One. 2017;12:e0182380.","journal-title":"PLoS One"},{"key":"3773_CR137","first-page":"16","volume":"37","author":"The-European-Commission","year":"2022","unstructured":"The European Commission. Commission implementing regulation (EU) 2022\/214 of February 17 2022. OJEU. 2022;37:16\u201325.","journal-title":"OJEU"},{"key":"3773_CR138","unstructured":"Blasco JM. Estado actual de la brucelosis en Espa\u00f1a. 2003. https:\/\/www.colvema.org\/PDF\/BRUCELOSIS.pdf. Accessed 14 Aug 2023."},{"key":"3773_CR139","unstructured":"Ministerio de Agricultura Pesca y Alimentaci\u00f3n, Direcci\u00f3n General de Sanidad de la Producci\u00f3n Agraria. Programa nacional de vigilancia y control de la brucelosis bovina (infecci\u00f3n por B. abortus, B. melitensis y B. suis). 2021. https:\/\/www.mapa.gob.es\/es\/ganaderia\/temas\/sanidad-animal-higiene-ganadera\/programabb2021versionabril_tcm30-561035.pdf. Accessed 13 Aug 2023."},{"key":"3773_CR140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fmicb.2014.00213","volume":"5","author":"E Moreno","year":"2014","unstructured":"Moreno E. Retrospective and prospective perspectives on zoonotic brucellosis. Front Microbiol. 2014;5:213.","journal-title":"Front Microbiol"},{"key":"3773_CR141","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0167-5877(03)00048-5","volume":"58","author":"GT Fosgate","year":"2003","unstructured":"Fosgate GT, Adesiyun AA, Hird DW, et al. Evaluation of brucellosis RB51 vaccine for domestic water buffalo (Bubalus bubalis) in Trinidad. Prev Vet Med. 2003;58:211\u201325.","journal-title":"Prev Vet Med"},{"key":"3773_CR142","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0264-410X(95)93317-3","volume":"13","author":"MP de Jim\u00e9nezBag\u00fc\u00e9s","year":"1995","unstructured":"Jim\u00e9nez de Bag\u00fc\u00e9s MP, Barber\u00e1n M, Mar\u00edn CM, Blasco JM. The Brucella abortus RB51 vaccine does not confer protection against Brucella ovis in rams. Vaccine. 1995;13:301\u20134.","journal-title":"Vaccine"},{"key":"3773_CR143","doi-asserted-by":"crossref","first-page":"741","DOI":"10.20506\/rst.20.3.1305","volume":"20","author":"AH El-Idrissi","year":"2001","unstructured":"El-Idrissi AH, Benkirane A, El-Maadoudi M, Bouslikhane M, Berrada J, Zerouali A. Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Rev Sci Tech Off Int Epiz. 2001;20:741\u20137.","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"3773_CR144","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.2460\/ajvr.67.10.1802","volume":"67","author":"WC Stoffregen","year":"2006","unstructured":"Stoffregen WC, Olsen SC, Bricker BJ. Parenteral vaccination of domestic pigs with Brucella abortus strain RB51. Am J Vet Res. 2006;67:1802\u20138. https:\/\/doi.org\/10.2460\/ajvr.67.10.1802.","journal-title":"Am J Vet Res"},{"key":"3773_CR145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7589\/0090-3558-27.2.258","volume":"27","author":"DS Davis","year":"1991","unstructured":"Davis DS, Templeton JW, Ficht TA, Huber JD, Angus RD, Adams GL. Brucella abortus in bison. II. Evaluation of strain 19 vaccination of pregnant cows. J Wildl Dis. 1991;27:258\u201364.","journal-title":"J Wildl Dis"},{"key":"3773_CR146","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/CVI.00419-08","volume":"16","author":"SC Olsen","year":"2009","unstructured":"Olsen SC, Boyle SM, Schurig G, Sriranganathan N. Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strains RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes. Clin Vaccine Immunol. 2009;16:553\u2013540.","journal-title":"Clin Vaccine Immunol"},{"key":"3773_CR147","doi-asserted-by":"crossref","first-page":"18","DOI":"10.7589\/0090-3558-38.1.18","volume":"38","author":"WE Cook","year":"2002","unstructured":"Cook WE, Williams ES, Thorne ET, et al. Brucella abortus strain RB51 vaccination in elk. I. Efficacy of reduced dosage. J Wildl Dis. 2002;38:18\u201326.","journal-title":"J Wildl Dis"},{"key":"3773_CR148","doi-asserted-by":"crossref","first-page":"477","DOI":"10.7589\/0090-3558-36.3.477","volume":"36","author":"TJ Kreeger","year":"2000","unstructured":"Kreeger TJ, Miller MW, Wild MA, Elzer PH, Olsen SC. Safety and efficacy of Brucella abortus strain RB51 vaccine in captive pregnant elk. J Wildl Dis. 2000;36:477\u201383.","journal-title":"J Wildl Dis"},{"key":"3773_CR149","unstructured":"WHO. The development of new\/improved brucellosis vaccines: Report of WHO Meeting. WHO\/EMC\/ZDI\/98.14. 1999. https:\/\/apps.who.int\/iris\/handle\/10665\/65512?show=full. Accessed 9 Aug 2023."},{"key":"3773_CR150","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1037\/xge0000098","volume":"144","author":"LK Fazio","year":"2015","unstructured":"Fazio LK, Brashier NM, Payne BK, Marsh EJ. Knowledge does not protect against illusory truth. J Exp Psychol Gen. 2015;144:993\u20131002.","journal-title":"J Exp Psychol Gen"},{"key":"3773_CR151","doi-asserted-by":"crossref","first-page":"207","DOI":"10.20506\/rst.32.1.2201","volume":"32","author":"SC Olsen","year":"2013","unstructured":"Olsen SC. Recent developments in livestock and wildlife brucellosis vaccination. Rev Sci Tech Off Int Epiz. 2013;32:207\u201317.","journal-title":"Rev Sci Tech Off Int Epiz"},{"key":"3773_CR152","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1389201014666131226123016","volume":"14","author":"Z Wang","year":"2013","unstructured":"Wang Z, Wu Q. Research progress in live attenuated Brucella vaccine development. Curr Pharm Biotechnol. 2013;14:887\u201396. https:\/\/doi.org\/10.2174\/1389201014666131226123016.","journal-title":"Curr Pharm Biotechnol"},{"key":"3773_CR153","doi-asserted-by":"publisher","unstructured":"Dorneles EMS, Martins de Oliveira M, Pereira C, Oliveira I, Godfroid J, Lage A. Efficacy of Brucella abortus S19 and RB51 vaccine strains: a systematic review and meta-analysis. Transbound Emerg Dis. 20211\u201320. https:\/\/doi.org\/10.1111\/tbed.14440.","DOI":"10.1111\/tbed.14440"},{"key":"3773_CR154","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/14787210.2022.2066521","volume":"20","author":"A Darbandi","year":"2022","unstructured":"Darbandi A, Koupaei M, Navidifar T, Shahroodian S, Heidary M, Talebi M. Brucellosis control methods with an emphasis on vaccination: a systematic review. Expert Rev Anti Infect Ther. 2022;20:1025\u201335. https:\/\/doi.org\/10.1080\/14787210.2022.2066521.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"3773_CR155","doi-asserted-by":"publisher","first-page":"669196","DOI":"10.3389\/fcimb.2021.669196","volume":"11","author":"S Ryskeldinova","year":"2021","unstructured":"Ryskeldinova S, Zinina N, Kydyrbayev Z, et al. Registered influenza viral vector-based Brucella abortus vaccine for cattle in Kazakhstan: Age-wise safety and efficacy studies. Front Cell Infect Microbiol. 2021;11:669196. https:\/\/doi.org\/10.3389\/fcimb.2021.669196.","journal-title":"Front Cell Infect Microbiol"},{"key":"3773_CR156","unstructured":"Manthei CA. Summary of controlled research with strain 19. Proc 63rd Annu Meet US Livestock Sanit Assoc; 1959. p. 128."},{"key":"3773_CR157","doi-asserted-by":"publisher","first-page":"e00073","DOI":"10.1128\/CMR.00073-19","volume":"33","author":"P Yagupsky","year":"2019","unstructured":"Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev. 2019;33:e00073-e119. https:\/\/doi.org\/10.1128\/CMR.00073-19.","journal-title":"Clin Microbiol Rev"},{"key":"3773_CR158","unstructured":"CDC (U.S.A.). Third case of rifampin\/penicillin-resistant strain of RB51 Brucella from consuming raw milk. 2019. https:\/\/stacks.cdc.gov\/view\/cdc\/62370. Accessed 9 Aug 2023."},{"key":"3773_CR159","unstructured":"Blackmore E, Guarin A, Alonso S, Grace D, Vorley B. Informal milk markets in Kenya, Tanzania and Assam (India): An overview of their status, policy context, and opportunities for policy innovation to improve health and safety. ILRI Research Report 62, Nairobi, Kenia, ILR. 2020"},{"key":"3773_CR160","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4178\/EPIH.E2020073","volume":"42","author":"AAP Milton","year":"2020","unstructured":"Milton AAP, Das S, Ghatak S. Neglected paths of transmission for milkborne brucellosis and tuberculosis in developing countries: novel control opportunities. Epidemiol and health. 2020;42:1\u20134. https:\/\/doi.org\/10.4178\/EPIH.E2020073.","journal-title":"Epidemiol and health"},{"key":"3773_CR161","doi-asserted-by":"publisher","first-page":"105042","DOI":"10.1016\/j.actatropica.2019.105042","volume":"197","author":"I Musallam","year":"2019","unstructured":"Musallam I, Ndour AP, Yempabou D, et al. Brucellosis in dairy herds: A public health concern in the milk supply chains of West and Central Africa. Acta Trop. 2019;197:105042. https:\/\/doi.org\/10.1016\/j.actatropica.2019.105042.","journal-title":"Acta Trop"},{"key":"3773_CR162","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms8050752","volume":"8","author":"J Owusu-Kwarteng","year":"2020","unstructured":"Owusu-Kwarteng J, Akabanda F, Agyei D, Jespersen L. Microbial safety of milk production and fermented dairy products in Africa. Microorganisms. 2020;8:1\u201324. https:\/\/doi.org\/10.3390\/microorganisms8050752.","journal-title":"Microorganisms"},{"key":"3773_CR163","doi-asserted-by":"crossref","unstructured":"Stemke DJ. Genetically modified microorganisms. Biosafety and ethical issues. In: Parekh SR, editor. The GMO Handbook. Totowa, NJ. Humana Press; 2004. p. 85\u2013130.","DOI":"10.1007\/978-1-59259-801-4_4"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-023-03773-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T20:59:35Z","timestamp":1730321975000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-023-03773-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":163,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3773"],"URL":"https:\/\/doi.org\/10.1186\/s12917-023-03773-3","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"assertion":[{"value":"14 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}